Mediators of mucosal inflammation: Implications for therapy

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 223, 1997, Pages 92-98

  Van Dullemen, H ^a   Meenan, J ^b   Stronkhorst, A ^b   Tytgat, G N J ^b   Van Deventer, S J H ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Cytokines; Inflammatory bowel disease; Inflammatory mediators; Therapy

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; CHEMOKINE RECEPTOR; CYTOKINE; IMMUNOMODULATING AGENT; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; ZILEUTON; ARACHIDONIC ACID; AUTACOID; ICOSANOID;

ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; ENTERITIS; HUMAN; IMMUNOMODULATION; MEDIATOR; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ARACHIDONIC ACID; CYTOKINES; EICOSANOIDS; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; PLATELET ACTIVATING FACTOR;

EID: 0031005155     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Balfour Sartor R. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
2. Van den Bosch H. Intracellular phospholipase A. Biochem Biophys Acta 1980;604:101-246.
3. Schoenberg MH, Beger HO. Reperfusion injury after intestinal ischemia [review]. Crit Care Med 1993;21:1376-86.
4. Larsen GL, Henson PM. Mediators of inflammation. Am Rev Immunol 1983;1:335-59.
5. Irvine RF. How is the level of free arachidonic acid controlled in mammalian cells? Biochem J 1983;204:3-16.
6. Snyder F. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev 1985;5:107.
7. Pretland DJ, Djuric SW, Gaginella TS. Eicosanoids and inflammatory bowel disease: regulation and prospects for therapy. Prostaglandins Leukot Essent Fatty Acids 1990;41:215-33.
8. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis. Gastroenterology 1988;95:11-7.
9. Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Ito K, Toyota T. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease. Scand J Gastroenterol 1995;30:44-9.
10. Vadas P, Pruzanski W. Induction of group II phospolipase A2 expression and pathogenesis of the sepsis syndrome. Circ Shock 1993;39:160-7.
11. Vadas P. Plasma phospholipase A2 levels correlate with the hemodynamic and pulmonary changes in Gram negative shock in man. J Lab Clin Med 1984;104:873-81.
12. Pruzanski WP, Vadas P, Stefanski E, Urowitz MB. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinfiammatory enzyme. J Rheumatol 1985;12:211-6.
13. Pruzanski W, Keystone EC, Sternby B, Bombardier C, Snow HM, Vadas P. Serum phospholipase A2 correlates with the disease activity in rheumatoid arthritis. J Reumatol 1988;15:1351-5.
14. Vadas P, Taylor TE, Chimsuku L, Goldring D, Stefanski E, Pruzanski W, Molyneux ME. Increased serum phospholipase A2 activity in Malawian children with falciparum malaria. Am J Trop Med Hyg 1993;49:455-9.
15. Rintala EM, Nevalainen TJ. Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections. Clin Infect Dis 1993;17:864-70.
16. Nevalainen TJ. The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 1980;15:641-50.
17. Minami T, Tojo H, Shinomural Y. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992;33:914-21.
18. Vadas P, Pruzanski W, Kim J, et al. The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2. Am J Pathol 1989;134:807-11.
19. Chang J, Gilman SC, Lewis AJ. Interleukin 1 activates phospholipase A2 in rabbit chondrocytes: A possible signal for IL-1 action. J Immunol 1989;136:1283-7.